Literature DB >> 27906817

Classifying Patients' Complaints for Regulatory Purposes: A Pilot Study.

Renée Bouwman1, Manja Bomhoff1, Paul Robben, Roland Friele.   

Abstract

OBJECTIVES: It is assumed that classifying and aggregated reporting of patients' complaints by regulators helps to identify problem areas, to respond better to patients and increase public accountability. This pilot study addresses what a classification of complaints in a regulatory setting contributes to the various goals.
METHODS: A taxonomy with a clinical, management, and relationship domain was used to systematically analyze 364 patients' complaints received by the Dutch regulator.
RESULTS: Most complaints were about hospital care, mental health care, and elder care. About certain sectors such as emergency care, little numbers of complaints were received. The largest proportion of complaints concerned the clinical domain (51%), followed by the management domain (47%) and the relationship domain (42%).Clinical domain complaints were more prevalent in elder care (65%) than in hospital care (56%) and mental health care (41%). In complaints about mental health care, the relationship domain was the most important (65%). The management domain was most prevalent in elder care (49%) compared with the other sectors.
CONCLUSIONS: Problem areas within different health-care sectors could be identified by classifying the complaints. It provided insight in the regulator's own practices, which are aimed at public accountability. However, there are several limitations. Aggregated analyses were not possible in sectors with low numbers of complaints. Furthermore, the information remains rather superficial, and a standardized detailed system of reporting among agencies is needed. To assess which complaints need regulatory action, an in-depth analysis, using standardized methodology and criteria, of specific complaints is needed. Improving responses to patients requires more than merely aggregated reporting of complaints.
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 27906817     DOI: 10.1097/PTS.0000000000000297

Source DB:  PubMed          Journal:  J Patient Saf        ISSN: 1549-8417            Impact factor:   2.844


  6 in total

1.  What methods are used to promote patient and family involvement in healthcare regulation? A multiple case study across four countries.

Authors:  Siri Wiig; Suzanne Rutz; Alan Boyd; Kate Churruca; Sophia Kleefstra; Cecilie Haraldseid-Driftland; Jeffrey Braithwaite; Jane O'Hara; Hester van de Bovenkamp
Journal:  BMC Health Serv Res       Date:  2020-07-06       Impact factor: 2.655

Review 2.  Learning from complaints in healthcare: a realist review of academic literature, policy evidence and front-line insights.

Authors:  Jackie van Dael; Tom W Reader; Alex Gillespie; Ana Luisa Neves; Ara Darzi; Erik K Mayer
Journal:  BMJ Qual Saf       Date:  2020-02-04       Impact factor: 7.035

3.  Involving Patients and Families in the Analysis of Suicides, Suicide Attempts, and Other Sentinel Events in Mental Healthcare: A Qualitative Study in The Netherlands.

Authors:  Renée Bouwman; Bert de Graaff; Derek de Beurs; Hester van de Bovenkamp; Ian Leistikow; Roland Friele
Journal:  Int J Environ Res Public Health       Date:  2018-05-29       Impact factor: 3.390

4.  Healthcare Complaints Analysis Tool: reliability testing on a sample of Danish patient compensation claims.

Authors:  Soren Bie Bogh; Jonas Harder Kerring; Katrine Prisak Jakobsen; Camilla Hagemann Hilsøe; Kim Mikkelsen; Søren Fryd Birkeland
Journal:  BMJ Open       Date:  2019-11-25       Impact factor: 2.692

5.  A SBM-DEA based performance evaluation and optimization for social organizations participating in community and home-based elderly care services.

Authors:  Qiuhu Shao; Jingfeng Yuan; Jin Lin; Wei Huang; Junwei Ma; Hongxing Ding
Journal:  PLoS One       Date:  2021-03-17       Impact factor: 3.240

6.  Patient-Centered Insights: Using Health Care Complaints to Reveal Hot Spots and Blind Spots in Quality and Safety.

Authors:  Alex Gillespie; Tom W Reader
Journal:  Milbank Q       Date:  2018-09       Impact factor: 4.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.